U.S. Markets open in 2 hrs 13 mins

Clarification: Amgen-Earnings Preview story

TRENTON, N.J. (AP) -- In a story July 26, The Associated Press reported that biotech drugmaker Amgen Inc. will make Japanese pharmaceutical company Astellas Pharma Inc. a wholly owned subsidiary of Amgen as soon as 2020. In fact, a joint venture of Amgen and Astellas will become a unit of Amgen. Parent Astellas Pharma Inc. will remain independent.